JP6004322B2 - 心血管イベントの発症リスクの検査方法 - Google Patents
心血管イベントの発症リスクの検査方法 Download PDFInfo
- Publication number
- JP6004322B2 JP6004322B2 JP2012099112A JP2012099112A JP6004322B2 JP 6004322 B2 JP6004322 B2 JP 6004322B2 JP 2012099112 A JP2012099112 A JP 2012099112A JP 2012099112 A JP2012099112 A JP 2012099112A JP 6004322 B2 JP6004322 B2 JP 6004322B2
- Authority
- JP
- Japan
- Prior art keywords
- onset
- platelets
- risk
- cardiovascular
- cli
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012099112A JP6004322B2 (ja) | 2012-04-24 | 2012-04-24 | 心血管イベントの発症リスクの検査方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012099112A JP6004322B2 (ja) | 2012-04-24 | 2012-04-24 | 心血管イベントの発症リスクの検査方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013228229A JP2013228229A (ja) | 2013-11-07 |
| JP2013228229A5 JP2013228229A5 (cg-RX-API-DMAC10.html) | 2015-06-18 |
| JP6004322B2 true JP6004322B2 (ja) | 2016-10-05 |
Family
ID=49676005
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012099112A Expired - Fee Related JP6004322B2 (ja) | 2012-04-24 | 2012-04-24 | 心血管イベントの発症リスクの検査方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6004322B2 (cg-RX-API-DMAC10.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021172493A1 (ja) * | 2020-02-28 | 2021-09-02 | 株式会社Lsiメディエンス | 可溶型clec-2と血小板数に基づく血小板活性化測定方法 |
| JP7584125B2 (ja) | 2020-11-02 | 2024-11-15 | 国立大学法人千葉大学 | 心血管イベントの発症リスクの検査方法 |
| JPWO2025075139A1 (cg-RX-API-DMAC10.html) * | 2023-10-06 | 2025-04-10 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602006013792D1 (de) * | 2005-02-18 | 2010-06-02 | Solvay Pharm Gmbh | Pharmazeutische zusammensetzungen mit nep-inhibitoren, inhibitoren des endogenes endothelin produzierenden systems und diuretika |
| WO2011027971A2 (ko) * | 2009-09-01 | 2011-03-10 | 주식회사이언메딕스 | 장내 공생 세균유래 세포밖 소포체, 및 이를 이용한 질병모델, 백신, 후보 약물 탐색 방법, 및 진단 방법 |
-
2012
- 2012-04-24 JP JP2012099112A patent/JP6004322B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013228229A (ja) | 2013-11-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zöller et al. | Red cell distribution width and risk for venous thromboembolism: a population-based cohort study | |
| Payancé et al. | Hepatocyte microvesicle levels improve prediction of mortality in patients with cirrhosis | |
| Lehner et al. | Oliguria and biomarkers of acute kidney injury: star struck lovers or strangers in the night? | |
| CN106461677B (zh) | 肺高血压病的检查方法 | |
| McCullough et al. | Neutrophil gelatinase-associated lipocalin: a novel marker of contrast nephropathy risk | |
| Akdur et al. | Diagnostic utility of hematological indices in predicting adverse outcomes and severity of acute pancreatitis based on BISAP and modified Glasgow score | |
| Koziel et al. | Comparative analysis of selected scales to assess prognosis in acute pancreatitis | |
| Ergül et al. | COVID 19 disease independently predicted endothelial dysfunction measured by flow-mediated dilatation | |
| Kim et al. | Plasma osteoprotegerin levels increase with the severity of cerebral artery atherosclerosis | |
| CN115190973B (zh) | 基于可溶性clec-2与血小板数的血小板活化测定方法 | |
| Nerkiz et al. | Serum pentraxin-3 level in patients who underwent coronary angiography and relationship with coronary atherosclerosis | |
| Ahmed et al. | The additive value of copeptin for early diagnosis and prognosis of acute coronary syndromes | |
| McLeod et al. | Common clinical markers predict end-stage renal disease in children with obstructive uropathy | |
| JP2013228229A (ja) | 心血管イベントの発症リスクの検査方法 | |
| Kaur et al. | Erythrocyte Sedimentation Rate: Its Determinants and Relationship with Risk Factors Involved in Ischemic Stroke | |
| Mirzaii-Dizgah et al. | Serum and saliva levels of cathepsin L in patients with acute coronary syndrome | |
| JP2007248395A (ja) | 急性冠症候群でのadamts13の測定と利用 | |
| JP7584125B2 (ja) | 心血管イベントの発症リスクの検査方法 | |
| JP2011196840A (ja) | 急性大動脈解離の検査方法 | |
| JP6316200B2 (ja) | サイクロフィリンaによる心血管疾患の検査方法 | |
| Sajeev et al. | High sensitivity troponin: Does the 50% delta change alter clinical outcomes in chest pain presentations to the emergency room? | |
| WO2022255348A1 (ja) | 可溶型clec2を用いた急性脳血管障害のリスク評価方法 | |
| Negreva et al. | Significant increase in C-reactive protein and serum amyloid A in the early hours of paroxysmal atrial fibrillation | |
| Ivandic et al. | High-sensitivity troponin T improves the prognostic value of N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: results from the LURIC Study. | |
| JP2020051911A (ja) | 心不全マーカー |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150424 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20150424 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20160209 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160216 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160418 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20160816 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20160826 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6004322 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |